Quest Diagnostics Incorporated
Quest Diagnostics Incorporated
Your view on DGX
Overview
What the company does, where it operates, and who runs it.
About Quest Diagnostics Incorporated
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- James E. Davis
- Headquarters
- 500 Plaza Drive, Secaucus, NJ, US
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- James E. Davis
- Headquarters
- 500 Plaza Drive, Secaucus, NJ, US
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals.
The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Quest Diagnostics Incorporated, and the rating behind it. DGX last traded at $242.95, 23.8× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Quest Diagnostics Incorporated. Starting points for Quest Diagnostics Incorporated: P/E 23.8, EPS $10.26, beta 0.54 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Quest Diagnostics Incorporated. Quest Diagnostics Incorporated paid $3.38 per share over the last year — a 1.4% yield at the current $242.95 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Quest Diagnostics Incorporated. Trailing twelve-month EPS for Quest Diagnostics Incorporated stands at $10.26. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Quest Diagnostics Incorporated. Quest Diagnostics Incorporated has reported as a listed company since 1996. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Quest Diagnostics Incorporated valued side by side against its closest peers. Quest Diagnostics Incorporated is measured against Medical - Diagnostics & Research peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Quest Diagnostics Incorporated, and how their positions are changing. At a $26.82B market value, institutional positions materially move Quest Diagnostics Incorporated's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Quest Diagnostics Incorporated executives and directors. Shares of Quest Diagnostics Incorporated have traded between $148.70 and $197.55 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Quest Diagnostics Incorporated. Quest Diagnostics Incorporated is a $26.82B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Quest Diagnostics Incorporated. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Quest Diagnostics Incorporated. Coverage tracks Quest Diagnostics Incorporated within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.